Literature DB >> 8112326

Expression of properdin in human monocytes.

W Schwaeble1, H P Huemer, J Möst, M P Dierich, M Ströbel, C Claus, K B Reid, H W Ziegler-Heitbrock.   

Abstract

Properdin is the only known positive regulator of the alternative pathway of complement activation. Northern blot analysis of cell lines derived from fibroblasts, B-cells, hepatoma cells, and cells of the monocyte-macrophage lineage revealed properdin expression only in the myelomonocytic cell line HL-60, in the monoblastic cell line U-937 and in the monocytic line Mono Mac 6. Culture of Mono Mac 6 cells for 24 h with phorbol 12-myristate 13-acetate, bacterial lipopolysaccharide and the cytokines interleukin-1 beta and tumour necrosis factor-alpha enhanced mRNA abundance, with the strongest effect (tenfold) being observed with the lipopolysaccharide. In contrast, recombinant interferon-gamma consistently halved properdin mRNA abundance. The same pattern was found for the secretion of properdin as detected by ELISA of Mono Mac 6 supernatants. The suppressive effect of interferon-gamma on properdin mRNA abundance was also demonstrated for primary blood monocytes. The data suggest that the expression and secretion of this complement regulatory protein by monocytes is differentially regulated by cytokines and link the immune response with alternative pathway activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112326     DOI: 10.1111/j.1432-1033.1994.tb18555.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  25 in total

1.  Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.

Authors:  Viviana P Ferreira; Claudio Cortes; Michael K Pangburn
Journal:  Immunobiology       Date:  2010-02-12       Impact factor: 3.144

2.  Native properdin binds to Chlamydia pneumoniae and promotes complement activation.

Authors:  Claudio Cortes; V P Ferreira; Michael K Pangburn
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

3.  Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.

Authors:  Yuko Kimura; Lin Zhou; Takashi Miwa; Wen-Chao Song
Journal:  J Clin Invest       Date:  2010-10       Impact factor: 14.808

4.  Properdin homeostasis requires turnover of the alternative complement pathway.

Authors:  Xiaobo Wu; Thomas Q Xu; John P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

5.  Tissue-specific induction of ADAMTS2 in monocytes and macrophages by glucocorticoids.

Authors:  Thomas P J Hofer; Marion Frankenberger; Jörg Mages; Roland Lang; Peter Meyer; Reinhard Hoffmann; Alain Colige; Löms Ziegler-Heitbrock
Journal:  J Mol Med (Berl)       Date:  2007-12-14       Impact factor: 4.599

Review 6.  Production of complement components by cells of the immune system.

Authors:  R Lubbers; M F van Essen; C van Kooten; L A Trouw
Journal:  Clin Exp Immunol       Date:  2017-03-24       Impact factor: 4.330

7.  Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation.

Authors:  Yuan Wang; Takashi Miwa; Blerina Ducka-Kokalari; Imre G Redai; Sayaka Sato; Damodar Gullipalli; James G Zangrilli; Angela Haczku; Wen-Chao Song
Journal:  J Immunol       Date:  2015-06-26       Impact factor: 5.422

8.  Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations.

Authors:  G N Fredrikson; B Gullstrand; J Westberg; A G Sjöholm; M Uhlén; L Truedsson
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

Review 9.  Properdin: New roles in pattern recognition and target clearance.

Authors:  Claudia Kemper; Dennis E Hourcade
Journal:  Mol Immunol       Date:  2008-08-08       Impact factor: 4.407

10.  CD16+ monocytes give rise to CD103+RALDH2+TCF4+ dendritic cells with unique transcriptional and immunological features.

Authors:  Vanessa Sue Wacleche; Amélie Cattin; Jean-Philippe Goulet; Dominique Gauchat; Annie Gosselin; Aurélie Cleret-Buhot; Yuwei Zhang; Cécile L Tremblay; Jean-Pierre Routy; Petronela Ancuta
Journal:  Blood Adv       Date:  2018-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.